BIO-TECHNE ($TECH) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of $0.56 per share, beating estimates of $0.52 by $0.04. The company also reported revenue of $316,180,000, missing estimates of $323,882,017 by $-7,702,017.
You can see Quiver Quantitative's $TECH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIO-TECHNE Insider Trading Activity
BIO-TECHNE insiders have traded $TECH stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $TECH stock by insiders over the last 6 months:
- KIM KELDERMAN (Chief Executive Officer) has made 0 purchases and 2 sales selling 13,392 shares for an estimated $1,035,013.
- AMY E. HERR sold 1,860 shares for an estimated $122,690
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BIO-TECHNE Hedge Fund Activity
We have seen 264 institutional investors add shares of BIO-TECHNE stock to their portfolio, and 275 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,229,954 shares (+13.1%) to their portfolio in Q4 2024, for an estimated $88,593,586
- POINT72 ASSET MANAGEMENT, L.P. removed 1,122,527 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $80,855,619
- MILLENNIUM MANAGEMENT LLC removed 616,150 shares (-48.4%) from their portfolio in Q4 2024, for an estimated $44,381,284
- BROWN ADVISORY INC added 599,982 shares (+45.7%) to their portfolio in Q1 2025, for an estimated $35,176,944
- CITADEL ADVISORS LLC added 553,590 shares (+46.0%) to their portfolio in Q4 2024, for an estimated $39,875,087
- SELECT EQUITY GROUP, L.P. added 495,404 shares (+26.9%) to their portfolio in Q4 2024, for an estimated $35,683,950
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 472,847 shares (+18.5%) to their portfolio in Q1 2025, for an estimated $27,723,019
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BIO-TECHNE Congressional Stock Trading
Members of Congress have traded $TECH stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $TECH stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/29, 04/09 and 0 sales.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 02/25.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
